23 June 2025

Simple Measures are Effective in Knee Osteoarthritis

Knee braces, water therapy and exercise are the most promising non-drug therapies for treating knee osteoarthritis, according to a new meta-analysis publishing June 18, 2025 in the open-access journal PLOS One by Yuan Luo of the First People’s Hospital of Neijiang, China.

Knee osteoarthritis (KOA) is a common and often debilitating condition that affects millions of older adults, causing pain and stiffening of the knee joint. Treatment often includes anti-inflammatory drugs, which are linked to gastrointestinal and cardiovascular adverse events.

Does Abatacept Buy You Time Off RA? Dr. David Liew reports on abstract OP0325 presented at the 2025 EULAR meeting in B

Tweet Author

RheumNow

Tweet Content

Does Abatacept Buy You Time Off RA? Dr. David Liew reports on abstract OP0325 presented at the 2025 EULAR meeting in Barcelona, Spain. https://t.co/t8NLvPjcju https://t.co/bloTKQ87rv

Links

Does Abatacept Buy You Time Off RA? | RheumNow https://buff.ly/E4pxW4o

Not All About B Cells: Myeloid Related Inflammation in Lupus Pathogenesis Dr. Andrea Fava shares his perspectives from

Tweet Author

RheumNow

Tweet Content

Not All About B Cells: Myeloid Related Inflammation in Lupus Pathogenesis Dr. Andrea Fava shares his perspectives from the EULAR 2025 meeting in Barcelona, Spain. https://t.co/8Lh02c3sy4 https://t.co/XX7wKovD9u

Links

Not All About B Cells: Myeloid Related Inflammation in Lupus Pathogenesis | Rhe… https://buff.ly/VNU1B5j

Social Determinants of Health in SLE Dr. Mrinalini Dey interviews Dr. Elena Nikiphorou about the topic of social deter

Tweet Author

RheumNow

Tweet Content

Social Determinants of Health in SLE Dr. Mrinalini Dey interviews Dr. Elena Nikiphorou about the topic of social determinants of health in systemic lupus erythematosus, and data being presented at the EULAR 2025 meeting in Barcelona, Spain. https://t.co/gSFIV8uIuE https://t.co/VpqzVRSwh9

Links

Social Determinants of Health in SLE | RheumNow https://buff.ly/uRCyFgs

Add-on certolizumab in pregnant women with APS Women with antiphospholipid syndrome and lupus anti-coagulant are at hi

Tweet Author

RheumNow

Tweet Content

Add-on certolizumab in pregnant women with APS Women with antiphospholipid syndrome and lupus anti-coagulant are at high risk of developing adverse pregnancy outcomes (APO). Usual care includes low molecular weight heparin (LMWH) and low dose aspirin (LDA). https://t.co/qnnkFlhtiS

Secukinumab & Uveitis = Unclear? Post hoc study of 11 SEC RCTs finds lower uveitis risk in AxSpA (N 1980; SEC 150

Tweet Author

RheumNow

Tweet Content

Secukinumab & Uveitis = Unclear? Post hoc study of 11 SEC RCTs finds lower uveitis risk in AxSpA (N 1980; SEC 150 1.29/100PYs vs 1.72/100PY in PBO), but not in PsA (N 2453; SEC 300 0.71/100PY vs zero w/ placebo) https://t.co/Gv9HheBU7l https://t.co/SlnrLRwmmn

Links

Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post… https://buff.ly/4fi93Wo

Predicting Psoriatic Arthritis in Psoriasis: How Close Are We? Psoriatic arthritis (PsA) affects approximately 30% of

Tweet Author

RheumNow

Tweet Content

Predicting Psoriatic Arthritis in Psoriasis: How Close Are We? Psoriatic arthritis (PsA) affects approximately 30% of patients with psoriasis (PsO), and diagnostic delays are associated with worse prognosis, making early detection crucial. At EULAR 2025, several studies https://t.co/RLz1FoQxvc

Nurse-Led Treat-to-Target Clinics New studies shared at the 2025 annual EULAR congress in Barcelona highlight the bene

Tweet Author

RheumNow

Tweet Content

Nurse-Led Treat-to-Target Clinics New studies shared at the 2025 annual EULAR congress in Barcelona highlight the benefits that nurse-led care can bring for both patients and healthcare systems. https://t.co/sV8IHhnwbm https://t.co/IrJKvceyez

Links

Nurse-Led Treat-to-Target Clinics | RheumNow https://buff.ly/9p7zJkA

How to properly use steroids in early RA Guidelines differ on the early treatment of RA – ACR suggests not to use gl

Tweet Author

RheumNow

Tweet Content

How to properly use steroids in early RA Guidelines differ on the early treatment of RA – ACR suggests not to use glucocorticoids (GC) and EULAR updated recommendations for RA treatment presented at #EULAR2025 continued to suggest early treatment with MTX and glucocorticoids. https://t.co/FakKxRot0p

Topics

Does Abatacept Buy You Time Off RA? Dr. David Liew reports on abstract OP0325 presented at the 2025 EULAR meeting in B

Not All About B Cells: Myeloid Related Inflammation in Lupus Pathogenesis Dr. Andrea Fava shares his perspectives from

Social Determinants of Health in SLE Dr. Mrinalini Dey interviews Dr. Elena Nikiphorou about the topic of social deter

Add-on certolizumab in pregnant women with APS Women with antiphospholipid syndrome and lupus anti-coagulant are at hi

Secukinumab & Uveitis = Unclear? Post hoc study of 11 SEC RCTs finds lower uveitis risk in AxSpA (N 1980; SEC 150

Predicting Psoriatic Arthritis in Psoriasis: How Close Are We? Psoriatic arthritis (PsA) affects approximately 30% of

Nurse-Led Treat-to-Target Clinics New studies shared at the 2025 annual EULAR congress in Barcelona highlight the bene

How to properly use steroids in early RA Guidelines differ on the early treatment of RA – ACR suggests not to use gl

IL-17 Inhibitors in Psoriatic Arthritis

Do you get our email newsletter?